業績

国際学会

International STROKE Conference 2015, Nashville, USA, 2015/2/11-13

Three-month outcomes in Japanese stroke / TIA patients with non-valvular atrial fibrillation after initiating oral anticoagulants: The SAMURAI-NVAF Study.

Arihiro S, Toyoda K

▲上に戻る

The 12th Korean and Japanese Friendship Conference on Surgery for Cerebral Stroke, Osaka, Japan, 2014/9/26-27

Secondary stroke prevention; lesson from SAMURAI-NVAF Study.

Toyoda K

▲上に戻る

Asia Pacific Stroke Conference, Taipei, Taiwan, 2014/9/12-14

Blood pressure management for acute intracerebral hemorrhage: the SAMURAI-ICH study. (Invited speaker)

Koga M, Minematsu K, Toyoda K, for the SAMURAI-ICH Investigators

▲上に戻る

European Stroke Conference, Nice, France, 2014/5/6-9

Blood glucoses at 24 and 72 hours after admission are independently associated with 3-month clinical outcomes in acute intracerebral hemorrhage: The SAMURAI-ICH Study.

Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

International Stroke Conference 2014. San Diego, USA, 2014/2/11-14

Intravenous nicardipine dosage for blood pressure lowering in acute intracerebral hemorrhage: the SAMURAI-ICH study.

Koga M, Arihiro S, Hasegawa Y, Shiokawa Y, Okada Y, Kimura K, Furui E, Nakagawara J, Yamagami H, Kario K, Okuda S, Tokunaga K, Takizawa H, Takasugi J, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

Clinical significance of continuous antihypertensive therapy throughout the initial 24 hours in hyperacute intracerebral hemorrhage: The SAMURAI-ICH Study.

Kobayashi J, Koga M, Tanaka E, Okada Y, Kimura K, Yamagami H, Okuda S, Hasegawa Y, Shiokawa Y, Furui E, Nakagawara J, Kario K, Okata T, Arihiro S, Sato S, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

Conjugate Eye Deviation in Acute Intracerebral Hemorrhage: Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) -ICH Study.

Sato S, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

Choice of warfarin and novel oral anticoagulants for secondary prevention of stroke/TIA in Japanese NVAF patients: the SAMURAI-NVAF study.

Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Shiokawa Y, Kamiyama K, Terasaki T, Okada Y, Nagakane Y, Mochizuki H, Takizawa S, Hasegawa Y, Okuda S, Furui E, Ito Y, Nakashima T, Kario K, Kameda T, Takamatsu K, Nishiyama K, SAMURAI Study Investigators

▲上に戻る

Length of stay and hospital charges in Japanese NVAF inpatients with acute stroke/TIA: the SAMURAI-NVAF study.

Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Shiokawa Y, Kamiyama K, Terasaki T, Okada Y, Nagakane Y, Mochizuki H, Takizawa S, Hasegawa Y, Okuda S, Furui E, Ito Y, Nakashima T, Kario K, Kameda T, Takamatsu K, Nishiyama K, Sato S, Koga M, The SAMURAI Study Investigators

▲上に戻る

Intravenous thrombolysis using low-dose alteplase for nonagenarians with acute ischemic stroke: the SAMURAI rtPA Registry.

Hayakawa M, Koga M, Sato S, Arihiro S, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Hasegawa Y, Yamagami H, Okada Y, Okuda S, Kario K, Minematsu K, Toyoda K

▲上に戻る

Atrial fibrillation unidentified prior to stroke/TIA: background features, stroke severity and outcome - the SAMURAI-NVAF study.

Homma K, Toyoda K, Takizawa S, Todo K, Kimura K, Shiokawa Y, Kamiyama K, Terasaki T, Okada Y, Nagakane Y, Mochizuki H, Hasegawa Y, Okuda S, Furui E, Ito Y, Nakashima T, Kario K, Kameda T, Takamatsu K, Nishiyama K, Arihiro S, Yamagami H, Kobayashi J, Sato S, Koga M

▲上に戻る

The 6th Korea-Japan Joint Stroke Conference, Osaka, Japan, 2013/10/5-6

Systolic blood pressure lowering≤160mmHg and achieved systolic blood pressure in hyperacute intracerebral hemorrhage: the SAMURAI-ICH study.

Koga M, Sakamoto Y, Minematsu K, Toyoda K

▲上に戻る

Anticoagulant medication for secondary prevention of stroke/TIA in Japanese NVAF patients in the NOAC era: an interim report of the SAMURAI-NVAF study.

Toyoda K, Arihiro S, Todo K, Kimura K, Shiokawa Y, the SAMURAI study investigators

▲上に戻る

International Stroke Conference 2013, Hawaii, USA, 2013/2/5-7

Intravenous thrombolysis for patients with reverse MRA-DWI mismatch: SAMURAI and NCVC rt-PA registries.

Sakamoto Y, Koga M, Kimura K, Nagatsuka K, Okuda S, Kario K, Hasegawa Y, Okada Y, Yamagami H, Furui E, Nakagawara J, Shiokawa Y, Okata T, Kobayashi J, Tanaka E, Minematsu K, Toyoda K

▲上に戻る

Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation.

Sakamoto Y, Sato S, Kuronuma Y, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) -ICH study.

Sato S, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Nagatsuka K, Minematsu K, Toyoda K

▲上に戻る

Reduced estimated glomerular filtration rate and outcomes of intracerebral hemorrhage: the SAMURAI-ICH study.

Miyagi T, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Osaki M, Kobayashi J, Okata T, Sakamoto Y, Tanaka E, Minematsu K, Toyoda K

▲上に戻る

World Stroke Congress 2012, Brasilia, Brazil, 2012/10/10-13

Is systolic blood pressure lowering to ≤160 mmHg for acute intracerebral hemorrhage safe? (oral presentation)

Koga M, Toyoda K and SAMURAI-ICH Study Investigators

▲上に戻る

Asia Pacific Stroke Conference 2012, Tokyo, Japan, 2012/9/10-12

Current status of intravenous rt-PA therapy in Japan from the SAMURAI rt-PA registry and others (Teaching Course).

Koga M

▲上に戻る

NIHSS-time score predicts outcomes in rt-PA patients: SAMURAI rt-PA registry.

Aoki J, Kimura K, Koga M, Kario K, Nakagawara J, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Yamagami H, Okada Y, Shibazaki K, Sakamoto Y, Toyoda K

▲上に戻る

Design and methods of the SAMURAI-NVAF study: a prospective, multicenter, observational study on anticoagulant therapy for Japanese stroke patients with nonvalvular atrial fibrillation.

Arihiro S, Koga M, Toyoda K and SAMURAI-NVAF Study Group

▲上に戻る

Thrombolysis and Acute Stroke Treatment (TAST) in 2011, New York City, USA 2011/12/1-3

ASPECTS on pretreatment diffusion weighted imaging for intravenous rt-PA therapy: SAMURAI rt-PA Registry. (oral presentation)

Koga M, Nezu T, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Minematsu K, Toyoda K

▲上に戻る

20th European Stroke Conference, Hamburg, Germany 2011/5/25-27

Moderately aggressive blood pressure lowering using intravenous nicardipine for acute intracerebral hemorrhage: an interim report of a prospective, multicenter, observational study. (oral presentation)

Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Minematsu K, Toyoda K

▲上に戻る

Edaravone Usage in Japanese Stroke Patients Treated with Intravenous Low-dose Recombinant Tissue Plasminogen Activator: the SAMURAI rt-PA Registry.

Noda T, Okuda S, Koga M, Sobue G, Shiokawa Y, Nakagawara J, Kimura K, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Naganuma M, Toyoda K

▲上に戻る

Initial 5-year results of intravenous rtPA using 0.6mg⁄kg alteplase in a single Japanese stroke center: NCVC rtPA registry.

Toyoda K, Koga M, Nagatsuka K, Osaki M, Minematsu K

▲上に戻る

International Stroke Conference 2011, Los Angeles, USA, 2011/2/9-11

Nationwide survey of expert opinions to restart anticoagulant therapy after intracerebral hemorrhage for patients with nonvalvular atrial fibrillation.

Maeda K, Koga M, Okada Y, Kimura K, Yamagami H, Okuda S, Hasegawa Y, Shiokawa Y, Furui E, Nakagawara J, Kario K, Nezu T, Endo K, Miyagi T, Minematsu K, Toyoda K

▲上に戻る

High-density lipoprotein cholesterol level is a predictor of outcome after intravenous recombinant tissue plasminogen activator therapy for acute stroke: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry.

Makihara N, Okada Y, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Hasegawa Y, Kario K, Okuda S, Naganuma M, Toyoda K

▲上に戻る

Intravenous rt-PA therapy for stroke patients without cerebral artery occlusion: SAMURAI Stroke Registry.

Miyagi T, Koga M, Nakagawara J, Shiokawa Y, Furui E, Kimura K, Yamagami H, Okada Y, Okuda S, Hasegawa Y, Kario K, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K

▲上に戻る

Female sex is associated with unfavorable outcomes following low-dose intravenous rt-PA therapy: the SAMURAI rt-PA Registry.

Nezu T, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Maeda K, Endo K, Miyagi T, Minematsu K, Toyoda K

▲上に戻る

Mechanical thrombectomy by the penumbra system has the potential to improve neurological and functional outcomes in japanese patient with acute ischemic stroke.

Sakai N, Toyoda K, JR-NET2 and SAMURAI study Investigators, for the Penumbra System Pivotal and POST Investigators

▲上に戻る

7th World Stroke Congress, Seoul, Korea, 2010/10/13-16

Intravenous low-dose rt-PA for ischemic stroke: SAMURAI rt-PA Registry. (Symposium)

Toyoda K

Association between treatment and outcomes in acute ischemic stroke with major cerebral artery occlusion.

Yamagami H, Sakai N, Endo K, Koga M, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators.

▲上に戻る

Etiology, clinical profiles, treatment, and outcomes of acute ischemic stroke with major cerebral artery occlusion in Japan.

Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Minematsu K, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators

▲上に戻る

Characteristics of acute stroke patients with major artery occlusion who did not receive recanalization therapy.

Koga M, Endo K, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Minematsu K, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators

▲上に戻る

Low-dose intravenous rt-PA therapy for acute stroke patients with basilar artery occlusion.

Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Naganuma M, Okuda S, Yamagami H, Okada Y, Minematsu K, Toyoda K, for the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators

▲上に戻る

Tiantan International Stroke Conference 2010, Beijing, China, 2010/6/25-27

Intravenous low-dose rt-PA for ischemic stroke: messages from SAMURAI rt-PA Registry. (Symposium)

Toyoda K

▲上に戻る

20th European Stroke Conference, Hamburg, Germany, 2010/5/25-28

Early Systolic Blood Pressure Variability is Associated with Stroke Outcome after Intravenous rt-PA : Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry.

Endo K, Kario K, Namekawa M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Okuda S, Miyagi T, Minematsu K, Toyoda K

▲上に戻る

Moderately aggressive blood pressure lowering using intravenous nicardipine for acute intracerebral hemorrhage: an interim report of a multicenter, prospective, observational study.

Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Minematsu K, Toyoda K

▲上に戻る

Edaravone usage in Japanese stroke patients treated with intravenous low-dose recombinant tissue plasminogen activator : the SAMURAI rt-PA Registry.

Noda T, Okuda S, Koga M, Sobue G, Shiokawa Y, Nakagawara J, Kimura K, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Naganuma M, Toyoda K

▲上に戻る

XVIIII. European Stroke Conference, Barcelona, Spain, 2010/5/25-28

Acute stroke management in Japan: insights from the SAMURAI study. (Symposium)

Toyoda K

▲上に戻る

Lower CHADS2 score is associated with favorable clinical outcomes in acute stroke patients with AF.

Koga M, Inoue Y, Toyoda K, Minematsu K

▲上に戻る

International Stroke Conference 2010, San Antonio, USA, 2010/2/24-26

Lower CHADS2 score is associated with favorable clinical outcome after intravenous rt-PA therapy in stroke patients with AF.

Koga M, Kimura K, Shibasaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Minematsu K, Toyoda K

▲上に戻る

Low-dose intravenous rt-PA therapy for stroke patients out of the indications by the European licence : the SAMURAI study.

Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K

▲上に戻る

Reduced estimated glomerular filtration rate is associated with stroke outcomes after intravenous low-dose rt-PA: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study.

Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K

▲上に戻る

Pre-treatment DWI-ASPECTS has a relation with functional outcome at 3 months following intravenous rt-PA therapy.

Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Minematsu K, Toyoda K

▲上に戻る

Pre-treatment DWI-ASPECTS is superior to ct-aspects in detecting excellent to fairly good outcome after intravenous rt-PA therapy.

Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Minematsu K, Toyoda K

▲上に戻る

Predictors of acute clinical deterioration in stroke patients receiving intravenous low-dose rt-PA : a multicenter observational study.

Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K

▲上に戻る

Impact of antiplatelet pre-treatment on intracranial hemorrhage and stroke outcome after intravenous thrombolysis : the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study.

Yamagami H, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Toyoda K

▲上に戻る

2009 Russia-United States-Japan Symposium on Cardiovascular Disease and Cancer, Osaka 2009/9/15

Intravascular treatment for cerebrovascular disease. (Symposium, panel discussion)

Toyoda K

▲上に戻る

XVIII. European Stroke Conference, Stockholm, Sweden 2009/5/26-29

Stroke features and outcome of 600 patients receiving intravenous low-dose rt-PA for ischemic stroke : a Japanese multicenter observational study.

Toyoda K, Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, for Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators

▲上に戻る

Expert Opinions on Hyperacute Blood Pressure Lowering in Patients with Intracerebral Hemorrhage

Koga M, Toyoda K, Naganuma M, Minematsu K for Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators

▲上に戻る